|
|
||||||||
Donner Laboratory, University of California, Berkeley, California
Correspondence: For reprints contact: H. S. Winchell, Donner Laboratory, University of California, Berkeley, Calif. 94720.
ABSTRACT
The polypeptide caseidin labeled with 99mTc using the Fe(III) plus ascorbate method, the Fe(II) method, the Sn(II) method, or labeled with 51Cr localizes in the renal cortex of mice, rats, and dogs. Fifteen minutes after i.v. administration of 99mTc-caseidin to mice, rats, and dogs approximately one third of the administered activity is in the kidneys and the ratio of activities in the kidney to that in the liver is 4.8:1.
Retention of 51Cr activity in the kidney is prolonged following administration of 51Cr-caseidin since in two dogs sacrificed 51 and 53 days after administration of 51Cr-caseidin radioactivity in the kidney was 50 and 40% of the activity remaining in the body, respectively. The pattern of retention of activity in mice which were germ free before administration of 51Cr-caseidin was different from that in mice which were not germ free.
The rapid accumulation of a large fraction of activity in the renal cortex following administration of 99mTc- or 51Cr-labeled caseidin suggests the usefulness of caseidin as a radionuclide carrier for renal studies.
The concentration and possible prolonged retention of labeled caseidin and other polypeptides in the renal cortex suggests a role of the kidney in the body's response to foreign protein. The possible nature of this role is discussed.
The initial intravascular distribution, subsequent rapid plasma clearance, and the molecular size of labeled caseidin indicate its possible suitability for imaging brain lesions.
FOOTNOTES
* Director of Polymer Dept., Weizmann Institute, Rehoveth, Israel, and Visiting Professor, Division of Medical Physics, University of California, Berkeley, Calif.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |